Pilot Bravo Bold Point Marker Pen- Black

Pilot Bravo Bold Point Marker Pen- Black

by Pilot Corporation of America

$1.95

Ready to use A pen requires no setup, pairing, or professional guidance — uncap and use immediately. Self_serve is clearly appropriate here.

Last verified June 17, 2026 · classified April 26, 2026

What it is

Summary

AI-generated from vendor-published content · April 26, 2026

This is a bold-tip marker pen that produces thick, high-contrast lines on paper, making handwritten text significantly easier to see. It's particularly useful for people with low vision who struggle to read back their own faint ballpoint writing — the wide ink line improves legibility for calendar entries, labels, and everyday notes. This is a complete, ready-to-use writing tool with no setup required. It's a single pen at a low price point, so stocking up makes sense if you use it regularly.

Quick Facts Catalog facts · auto-generated
Age range
ComplexityReady to use
Price$1.95
Funding
  • AT Act lending
  • Out of pocket
VerifiedJune 17, 2026
ClassifiedApril 26, 2026 · confidence: high

What Setup Looks Like

  • Out of the box
    Remove the cap and write — no setup needed.

Getting it

Try Before You Buy

Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.

Where to Get It

maxiaids Visit
$1.95

Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →

As an Amazon Associate we earn from qualifying purchases.

Wondering how equipment like this gets paid for? See the official funding programs in your state.

Sources & fine print

Vendor facts (name, price, platforms, vendor link) sourced from Pilot Corporation of Americaview on vendor site; last verified June 17, 2026.

Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.